Continuous intrathecal meperidine for severe refractory cancer pain: A case report

Clinical Journal of Pain

Volumn 21, Issue 2, 2005, Pages 193-196

  Souter, Karen J ^a   Davies, Joanne M ^a   Loeser, John D ^a   Fitzgibbon, Dermot R ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Analgesia; Bupivacaine; Cancer pain; Clonidine; Intrathecal; Meperidine; Patient controlled

Indexed keywords

BUPIVACAINE; CLONIDINE; FENTANYL; GABAPENTIN; HYDROMORPHONE; MORPHINE; NORPETHIDINE; PETHIDINE; PHENOL;

AGED; ARTICLE; CANCER PAIN; CASE REPORT; CORDOTOMY; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG CEREBROSPINAL FLUID LEVEL; HUMAN; MALE; NEUROLYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOSARCOMA; PAIN ASSESSMENT; PRIORITY JOURNAL; SIDE EFFECT;

ADULT; ANALGESICS, OPIOID; CORDOTOMY; HUMANS; INJECTIONS, SPINAL; MALE; MEPERIDINE; OSTEOSARCOMA; PAIN, INTRACTABLE; PALLIATIVE CARE; TREATMENT OUTCOME;

EID: 14044262251     PISSN: 07498047     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002508-200503000-00013     Document Type: Article

References (32)

1. World Health Organization. Cancer Pain Relief With a Guide to Opioid Availability. 1996.
2. Cleeland CS, Gonin R, Hatfield AK, et al. Pain and its treatment in outpatients with metastatic cancer. N Engl J Med. 1994;330:592-596.
3. Sjoberg M, Nitescu P, Appelgren L, et al. Long-term intrathecal morphine and bupivacaine in patients with refractory cancer pain. Results from a morphine: bupivacaine dose regimen of 0.5:4.75 mg/ml. Anesthesiology. 1994;80:284-297.
4. Sanders M, Zuurmond W. Safety of unilateral and bilateral percutaneous cervical cordotomy in 80 terminally ill cancer patients. J Clin Oncol. 1995;13:1509-1512.
5. Sjoberg M, Appelgren L, Einarsson S, et al. Long-term intrathecal morphine and bupivacaine in "refractory" cancer pain. I. Results from the first series of 52 patients. Acta Anaesthesiol Scand. 1991;35:30-43.
6. Mercadante S. Intrathecal morphine and bupivacaine in advanced cancer pain patients implanted at home. J Pain Symptom Manage. 1994;9:201-207.
7. Eisenach JC, DuPen S, Dubois M, et al. Epidural clonidine analgesia for intractable cancerpain. The Epidural Clonidine Study Group. Pain. 1995; 61:391-399.
8. Gerbershagen HU. Neurolysis. Subarachnoid neurolytic blockade. Acta Anaesthesiol Belg. 1981;32:45-57.
9. Meyerson BA. Neurosurgical approaches to pain treatment. Acta Anaesthesiol Scand. 2001;45:1108-1113.
10. Nagaro T, Adachi N, Tabo E, et al. New pain following cordotomy: clinical features, mechanisms, and clinical importance. J Neurosurg. 2001;95:425-431.
11. Ngan Kee WD. Intrathecal pethidine: pharmacology and clinical applications. Anaesth Intensive Care. 1998;26:137-146.
12. Latta KS, Ginsberg B, Barkin RL. Meperidine: a critical review. Am J Ther. 2002;9:53-68.
13. Patel D, Janardhan Y, Merai B, et al. Comparison of intrathecal meperidine and lidocaine in endoscopie urological procedures. Can J Anaesth. 1990;37:567-570.
14. Norris MC, Honet JE, Leighton BL, et al. A comparison of meperidine and lidocaine for spinal anesthesia for postpartum tubal ligation. Reg Anesth. 1996;21:84-88.
15. Izenwasser S, Newman AH, Cox BM, et al. The cocaine-like behavioral effects of meperidine are mediated by activity at the dopamine transporter. Eur J Pharmacol. 1996;297:9-17.
16. Wagner LE, Eaton M, Sabnis SS, et al. Meperidine and lidocaine block of recombinant voltage-dependent Na+ channels: evidence that meperidine is a local anesthetic. Anesthesiology. 1999;91:1481-1490.
17. Terman G, Bonica JJ. Spinal mechanisms and their modulation. In: Loeser JD, Butler SD, Chapman CR, et al, eds. Bonica's Management of Pain. 3rd ed. Philadelphia, PA: Lippincott Williams and Williams; 2001:73-152.
18. Magnan J, Paterson SJ, Tavani A, et al. The binding spectrum of narcotic analgesic drugs with different agonist and antagonist properties. Naunyn Schmiedebergs Arch Pharmacol. 1982;319:197-205.
19. Randic M, Cheng G, Kojic L. kappa-opioid receptor agonists modulate excitatory transmission in substantia gelatinosa neurons of the rat spinal cord. J Neurosci. 1995;15:6809-6826.
20. Bie B, Pan ZZ. Presynaptic mechanism for anti-analgesic and antihyperalgesic actions of kappa-opioid receptors. J Neurosci. 2003;23: 7262-7268.
21. Hustveit O. Binding of fentanyl and pethidine to muscarinic receptors in rat brain. Jpn J Pharmacol. 1994;64:57-59.
22. Famewo CE, Naguib M. Spinal anaesthesia with meperidine as the sole agent. Can Anaesth Soc J. 1985;32:533-537.
23. Naguib M, Famewo CE, Absood A. Pharmacokinetics of meperidine in spinal anaesthesia. Can Anaesth Soc J. 1986;33:162-166.
24. Honet JE, Arkoosh VA, Norris MC, et al. Comparison among intrathecal fentanyl, meperidine, and sufentanil for labor analgesia. Anesth Analg. 1992;75:734-739.
25. Kafle SK. Intrathecal meperidine for elective caesarean section: a comparison with lidocaine. Can J Anaesth. 1993;40:718-721.
26. Yu SC, Ngan Kee WD, Kwan AS. Addition of meperidine to bupivacaine for spinal anaesthesia for Caesarean section. Br J Anaesth. 2002;88:379-383.
27. Cousins MJ, Mather LE, Glynn CJ, et al. Selective spinal analgesia. Lancet. 1979;1:1141-1142.
28. Harvey SC, O'Neil MG, Pope CA, et al. Continuous intrathecal meperidine via an implantable infusion pump for chronic, nonmalignant pain. Ann Pharmacother. 1997;31:1306-1308.
29. Conway F. Critchley LA, Stuart JC, et al. A comparison of the haemodynamic effects of intrathecal meperidine, meperidine-bupivacaine mixture and hyperbaric bupivacaine. Can J Anaesth. 1996;43:23-29.
30. Booth JV, Lindsay DR, Olufolabi AJ, et al. Subarachnoid meperidine (Pethidine) causes significant nausea and vomiting during labor. The Duke Women's Anesthesia Research Group. Anesthesiology. 2000;93: 418-421.
31. Critchley LA, Chan S, Tam YH. Spectral analysis of sudden bradycardia during intrathecal meperidine anesthesia. Reg Anesth Pain Med. 1998;23:506-510.
32. Kaiko RF, Foley KM, Grabinski PY, et al. Central nervous system excitatory effects of meperidine in cancer patients. Ann Neurol. 1983;13:180-185.